Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease ; volume:15 ; number:1 ; day:31 ; month:8 ; year:2022 ; pages:1-16 ; date:12.2022
Journal of hematology & oncology ; 15, Heft 1 (31.8.2022), 1-16, 12.2022
- Urheber
-
Mohty, Razan
Hamed, Rama Al
Bazarbachi, Ali
Brissot, Eolia
Nagler, Arnon
Zeidan, Amer
Mohty, Mohamad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-022-01346-9
- URN
-
urn:nbn:de:101:1-2023011320592274082468
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mohty, Razan
- Hamed, Rama Al
- Bazarbachi, Ali
- Brissot, Eolia
- Nagler, Arnon
- Zeidan, Amer
- Mohty, Mohamad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical Hematology International: Why a New Journal in Hematology?
Looking Ahead: Clinical Hematology International Turns One
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini
Another Year to Celebrate Advances in Clinical Hematology
One Year into the COVID-19 Pandemic
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
Myelodysplastic syndromes
Myelodysplastic syndromes
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Clinical Hematology International: Why a New Journal in Hematology?
Looking Ahead: Clinical Hematology International Turns One
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini
Another Year to Celebrate Advances in Clinical Hematology
One Year into the COVID-19 Pandemic
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
Myelodysplastic syndromes
Myelodysplastic syndromes
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Clinical Hematology International: Why a New Journal in Hematology?
Looking Ahead: Clinical Hematology International Turns One
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
‘Standing on the Shoulders of the Giants’: Dr Rainer Storb
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini
Another Year to Celebrate Advances in Clinical Hematology
One Year into the COVID-19 Pandemic
‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
Myelodysplastic syndromes
Myelodysplastic syndromes
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better